
### [NCIT:C7866](http://purl.obolibrary.org/obo/NCIT_C7866)
**Label:** Recurrent Malignant Mesothelioma

**Subclasses:** [NCIT:C8707](http://purl.obolibrary.org/obo/NCIT_C8707) (Recurrent Pleural Malignant Mesothelioma), [NCIT:C8705](http://purl.obolibrary.org/obo/NCIT_C8705) (Recurrent Peritoneal Malignant Mesothelioma), [NCIT:C9253](http://purl.obolibrary.org/obo/NCIT_C9253) (Recurrent Pericardial Malignant Mesothelioma), 

**Class expressions from DL-Learner:**

- Thing 52.26%
- [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) 44.12%
- [NCIT:C36829](http://purl.obolibrary.org/obo/NCIT_C36829) (Abnormal Mesothelial Cell) 44.12%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) 41.61%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40377](http://purl.obolibrary.org/obo/NCIT_C40377) (Breast Follicular Lymphoma))) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40376](http://purl.obolibrary.org/obo/NCIT_C40376) (Breast Burkitt Lymphoma))) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40375](http://purl.obolibrary.org/obo/NCIT_C40375) (Breast Diffuse Large B-Cell Lymphoma))) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C4037](http://purl.obolibrary.org/obo/NCIT_C4037) (Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome))) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40369](http://purl.obolibrary.org/obo/NCIT_C40369) (Sebaceous Breast Carcinoma))) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40367](http://purl.obolibrary.org/obo/NCIT_C40367) (Acinic Cell Breast Carcinoma))) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40366](http://purl.obolibrary.org/obo/NCIT_C40366) (Oncocytic Breast Carcinoma))) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40363](http://purl.obolibrary.org/obo/NCIT_C40363) (Nipple Syringomatous Adenoma))) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40362](http://purl.obolibrary.org/obo/NCIT_C40362) (Low Grade Adenosquamous Breast Carcinoma))) 41.61%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40358](http://purl.obolibrary.org/obo/NCIT_C40358) (Squamous Cell Breast Carcinoma, Spindle Cell Variant))) 41.61%


